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Abstract
Oxidative stress is linked to many pathological conditions including the loss of dopaminergic
neurons in Parkinson’s disease. The vast majority of disease cases appear to be caused by
a combination of genetic mutations and environmental factors. We screened for genes pro-
tecting Caenorhabditis elegans dopaminergic neurons from oxidative stress induced by the
neurotoxin 6-hydroxydopamine (6-OHDA) and identified the transthyretin-related gene ttr-
33. The only described C. elegans transthyretin-related protein to date, TTR-52, has been
shown to mediate corpse engulfment as well as axon repair. We demonstrate that TTR-52
and TTR-33 have distinct roles. TTR-33 is likely produced in the posterior arcade cells in
the head of C. elegans larvae and is predicted to be a secreted protein. TTR-33 protects
C. elegans from oxidative stress induced by paraquat or H2O2 at an organismal level. The
increased oxidative stress sensitivity of ttr-33 mutants is alleviated by mutations affecting
the KGB-1 MAPK kinase pathway, whereas it is enhanced by mutation of the JNK-1 MAPK
kinase. Finally, we provide genetic evidence that the C. elegans cell corpse engulfment
pathway is required for the degeneration of dopaminergic neurons after exposure to 6-
OHDA. In summary, we describe a new neuroprotective mechanism and demonstrate that
TTR-33 normally functions to protect dopaminergic neurons from oxidative stress-induced
degeneration, potentially by acting as a secreted sensor or scavenger of oxidative stress.
Author summary
Animals employ multiple mechanisms to prevent their cells from damage by reactive oxy-
gen species, chemically reactive molecules containing oxygen. Oxidative stress, caused by
the overabundance of reactive oxygen species or a decreased cellular defence against these
chemicals, is linked to a variety of neurodegenerative conditions, including the loss of
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dopaminergic neurons in Parkinson’s disease. In this study, we discovered a novel protec-
tive molecule that functions to prevent dopaminergic neurodegeneration caused by oxida-
tive stress induced by the neurotoxin 6-hydroxydopamine (6-OHDA). We used the
nematode C. elegans, a well-characterised model in which mechanisms can be studied on
an organismal level. When C. elegans is exposed to 6-OHDA, its dopaminergic neurons
gradually die. Our major findings include (i) mutations of the transthyretin-related gene
ttr-33 causes highly increased dopaminergic neurodegeneration after 6-OHDA exposure;
(ii) TTR-33 is likely produced and secreted by several cells in the head of the animal; (iii)
TTR-33 protects against oxidative stress induced by other compounds; (iv) mutations in
the KGB-1 MAP kinase stress pathway alleviate dopaminergic neuron loss in the ttr-33
mutant; and (v) the cell corpse engulfment pathway is required for dopaminergic neuro-
degeneration. We hypothesise that TTR-33 protects dopaminergic neurons against 6-
OHDA-induced oxidative stress by acting as an oxygen sensor or scavenger.
Introduction
Oxidative stress, caused by an increased occurrence of reactive oxygen species or a decreased
cellular defence against these chemicals, is a risk factor for many pathological conditions
including Parkinson’s disease (for review [1]). The aetiology of Parkinson’s disease, which is
the second most abundant neurodegenerative disorder, is largely unknown (for review [2]).
Although approximately 10% of disease cases can be explained by single gene mutations, the
majority are thought to be evoked by the interplay of genetic defects and environmental factors
(for review [3,4]). One of the major hallmarks of Parkinson’s disease is the degeneration of
dopaminergic neurons in the substantia nigra of the midbrain, as well as the abnormal aggre-
gation of intracellular α-synuclein protein known as ‘Lewy bodies’ in surviving dopaminergic
neurons [4]. In both genetic and idiopathic cases of Parkinson’s disease, oxidative damage
appears to play an important role [4]. Several disease loci are associated with mitochondrial
function, and an increased incidence of Parkinson’s is associated with rural living, possibly
linked to pesticide exposure [4].
The nematode C. elegans is a powerful model system to understand how dopaminergic neu-
rons maintain their integrity when animals are subjected to oxidative stress. Components of
dopaminergic neurotransmission are highly conserved between C. elegans and mammals, and
dopaminergic neurons can be readily visualised in living animals (for review [5]). C. elegans
hermaphrodites possess eight dopaminergic neurons [6]. These are non-essential for viability
or locomotion, whereas they function in mechanosensation and are important for adapting
movement to nutrient availability [5].
C. elegans dopaminergic neurons have been used to mimic dopaminergic neurodegenera-
tion associated with exposure to known and suspected neurotoxins. One of these toxins is
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), exposure to which was discovered to
cause parkinsonism in a group of drug addicts [7]. In C. elegans, MPTP-induced neurodegen-
eration is independent of the CED-4 apoptosis protein and seems to be in part affected by
necrosis [8]. Exposure to manganese also leads to neurodegeneration in C. elegans [9,10], as
does treatment with paraquat and aflatoxin B1, agents that were recently implicated in dopami-
nergic neurodegeneration by causing genotoxic damage in mitochondria [11]. One of the
most intriguing agents that induces dopaminergic neurodegeneration in C. elegans and other
model organisms is 6-hydroxydopamine (6-OHDA), a neurotoxin related to dopamine (for
review [12]). 6-OHDA is specifically taken up into dopaminergic neurons by the dopamine
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transporter and leads to oxidative stress by blocking complex I of the respiratory chain [12].
When C. elegans are exposed to 6-OHDA, dopaminergic neurons gradually die [13]. It remains
underexplored which cell death pathways mediate dopaminergic neurodegeneration after
6-OHDA exposure, and which mechanisms limit their damage upon exposure to oxidative
stress.
Key features of apoptotic cell death and cell corpse engulfment mechanisms have been dis-
covered in C. elegans (for review [14]). The vast majority of C. elegans apoptotic cell deaths are
mediated by a conserved pathway comprised of a Apaf-1-like protein CED-4 and the CED-3
caspase (for review [14]). Apoptotic corpses and necrotic cells are engulfed and eliminated by
the corpse engulfment pathway [14]. In contrast to mammals, C. elegans does not possess spe-
cialised phagocytes, but dying cells are engulfed by surrounding cells (for review [15]). In addi-
tion, it has been shown that the engulfment pathway cooperates with the apoptotic pathway to
ensure efficient apoptosis [16,17]. Furthermore, there are several C. elegans cell deaths during
which engulfment is used for apoptosis-independent cell killing [18,19]. This type of cell
death, recently termed ‘phagoptosis’, also appears to occur in mammalian neurons which are
engulfed by surrounding glia cells (reviewed in [20]). When C. elegans dopaminergic neurons
die in response to 6-OHDA treatment, their neuronal processes exhibit blebbing and are the
first to degenerate [13]. Dying cell bodies exhibit condensed chromatin, a common feature of
apoptosis; however, blockage of apoptosis does not prevent neuronal death [13]. Typical fea-
tures of necrotic cell death, such as extensive swelling, do not occur, but dopaminergic neurons
were found to be surrounded by glia cells, consistent with a role of phagocytosis in 6-OHDA-
induced neurodegeneration [13].
Through an unbiased forward genetic screen, we have discovered that mutations in the C.
elegans transthyretin-related gene ttr-33 exacerbate dopaminergic neurodegeneration after
6-OHDA treatment. ttr-33 mutants also exhibit increased susceptibility to oxidative stress at
an organismal level. ttr-33 is one of the 59 C. elegans transthyretin-related genes, a family
resulting from a nematode-specific expansion [21,22]. Human transthyretin (transporter of
thyroxine (T4) and retinol) is synthesised mainly in the liver and the choroid plexus of the
brain, and binds and distributes retinol and thyroid hormones (for review [23]). Transthyretin
can form protein aggregates and has been connected to amyloid diseases [23]. The only char-
acterised C. elegans transthyretin-related protein, TTR-52, is a secreted protein that facilitates
apoptotic corpse engulfment by promoting recognition of apoptotic cells by engulfing cells
[24–26]. TTR-52 also mediates axonal repair during regeneration of severed neurons [27]. In
contrast, we speculate that TTR-33 may act as a sensor or scavenger of reactive oxygen species.
Interestingly, we find that mutations affecting the kgb-1 MAPK pathway reduce neurodegen-
eration in ttr-33 mutant animals. Finally, we provide genetic evidence that the C. elegans
engulfment pathway contributes to the removal of 6-OHDA-treated dopaminergic neurons.
Results
Mutations in the C. elegans transthyretin-related gene ttr-33 causes
enhanced 6-OHDA-induced dopaminergic neurodegeneration
Mutations in neuroprotective genes are expected to cause increased neuronal loss after oxidative
stress exposure. To discover genes that prevent dopaminergic neurodegeneration, we used a C.
elegans strain carrying the vtIs1 transgene, in which the promoter of the dopamine transporter
dat-1 drives GFP expression and thus allows selectively visualising the dopaminergic neurons
(Fig 1A). These animals (P0) were mutagenised with ethyl methanesulfonate, and L1 stage lar-
vae of the F2 generation were exposed to the neurotoxin 6-hydroxydopamine (6-OHDA) for 1
hour at 10 mM, a treatment that does not induce dopaminergic neurodegeneration in wild-type
Oxidative stress protection by the C. elegans transthyretin-related TTR-33
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Fig 1. ttr-33 mutations cause increased dopaminergic neurodegeneration after treatment with 6-OHDA. (A) GFP-labelled C. elegans dopaminergic head neurons–
4 cephalic sensilla (CEP) neurons and 2 anterior deirid (ADE) neurons–in animals carrying the vtIs1 transgene and neurodegeneration after addition of 6-OHDA. (B)
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animals. After 72 hours, the adult F2 population was screened for animals that exhibited
excessive loss of dopaminergic head neurons (Fig 1A). We isolated the gt1983mutant,
which exhibited highly increased 6-OHDA-induced neurodegeneration compared to wild-
type animals (Fig 1B). We found that the gt1983 allele is recessive as gt1983/wild-type(+)
heterozygous mutants did not exhibit increased 6-OHDA-induced neurodegeneration (Fig
1D). To identify the corresponding locus to the gt1983mutation, we performed whole-
genome sequencing and single-nucleotide polymorphism mapping [28,29]. We found that
the gt1983mutant carries a point mutation in ttr-33 (transthyretin-related family domain)
that causes a glycine to glutamate conversion (G27E) in the TTR-33 protein (Fig 1C).
Another ttr-33 point mutation, gk567379, which induces a leucine to phenylalanine substi-
tution (L72F) (Fig 1C), also caused hypersensitivity to 6-OHDA, albeit to a weaker extent
(Fig 1E). Furthermore, gt1983/ttr-33(gk567379) trans-heterozygous animals still exhibited
increased 6-OHDA-induced neurodegeneration (Fig 1E). Finally, transgenic expression of
wild-type ttr-33 under the control of a 1.5 kb endogenous regulatory region partially res-
cued the 6-OHDA-induced neurodegeneration defect of ttr-33 mutants (Fig 1F). Taken
together, our results indicate that loss-of-function mutations in the transthyretin-related
gene ttr-33 lead to increased 6-OHDA-induced dopaminergic neurodegeneration.
6-OHDA sensitivity of the ttr-33 mutant occurs in the first larval stages and
is inhibited by blocking neuronal drug uptake
TTR-33, like the majority of the C. elegans transthyretin-related proteins [24], is predicted to
be a secreted, non-cytoplasmic protein (S2A Fig). Apart from the small alpha-helical signal
peptide at the N-terminus, the predicted TTR-33 protein structure is composed predominantly
of beta sheets (Fig 2A; S2C Fig). According to this protein structure prediction, ttr-33(gt1983)
and ttr-33(gk567379) lead to amino acid changes on two neighbouring beta-strands (Fig 2A).
To determine the developmental stages in which ttr-33 functions to protect C. elegans from
6-OHDA-induced neurodegeneration, we exposed a mixed population of ttr-33 mutants to
this drug. The larval stages 1–4 (L1-L4) and adult animals were separated after treatment. We
found that L1 and L2 ttr-33 mutant larvae were highly sensitive to 6-OHDA, whereas L3 larvae
exhibited less sensitivity (Fig 2B). Mutant L4 larvae and adults did not show increased neuro-
degeneration (Fig 2B). We conclude that loss of function of ttr-33 causes 6-OHDA-induced
dopaminergic neurodegeneration in the first three larval stages of C. elegans.
Remaining dopaminergic head neurons 24, 48 and 72 hours after treatment with 10 mM 6-OHDA and 72 hours after control treatment with ascorbic acid only (‘72h
Ctr’) for BY200 wild-type and gt1983mutant animals. Animals possessing all neurons were scored as ‘ADE + CEP’ (white bar), those with partial loss of CEP but intact
ADE neurons as ‘ADE + partial CEP’ (light grey bar), those with complete loss of CEP but intact ADE neurons as ‘only ADE’ (dark grey bar) and those with complete
loss of dopaminergic head neurons as ‘no ADE + CEP’ (black bar). Error bars = S.E.M. of 3 biological replicates for all the other strains, each with 60–120 animals per
strain. Total number of animals per condition n = 30 for the ‘72h Ctr’ and n = 220–340 for all the other conditions (p<0.0001; G-Test comparing BY200 wild-type
and mutant data of the same time point). (C) ttr-33 gene structure with positions of ttr-33(gt1983) and ttr-33(gk567379)point mutations. Nucleotide and amino acid
changes are indicated in parentheses. (D) Dopaminergic head neurons after treatment with 10 mM 6-OHDA in BY200 wild-type animals and ttr-33(gt1983)
homozygous and ttr-33(gt1983)/+ heterozygous mutants. Error bars = SEM (Standard Error of the Mean) of 2 experiments, each with 50–105 animals per strain. Total
number of animals per strain n = 120–205 (p<0.0001, n.s. p>0.05; G-Test). (E) Dopaminergic head neurons after treatment with 10 mM 6-OHDA in BY200 wild-
type animals, gt1983 and ttr-33(gk567379)homozygous mutants and gt1983/ttr-33(gk567379) trans heterozygous mutant animals. Error bars = SEM of 2–3 experiments,
each with 100–175 animals per strain. Total number of animals per strain n = 210–340 (p<0.0001; G-Test). (F) Effect of Pttr-33::ttr-33 and Pbath-15::ttr-33
extrachromosomal arrays on dopaminergic neurodegeneration of ttr-33 mutant animals after treatment with 10 mM 6-OHDA. Error bars = SEM of 2 biological
replicates, each with 90–130 animals per strain and concentration. Total number of animals per condition n = 200–245 (p<0.0001, p<0.001, p<0.01, n.s.
p>0.05; G-Test). At present, we speculate that the ttr-33 mutant defect is not be fully rescued by our ttr-33 wild-type plasmids because of a 3 amino acid linker sequence
in the constructs. This linker sequence was introduced as part of the cloning strategy between the translational start site and the N-terminal secretion signal of TTR-33 and
may compromise protein function. It is also possible that the construct do not contain all promoter elements. As extrachromosomal arrays lead to variable expression
between tissues, it is possible that not all tested animals expressed TTR-33 in the arcade cells. Finally, overexpression of TTR-33 might interfere with its function.
https://doi.org/10.1371/journal.pgen.1007125.g001
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Fig 2. ttr-33 mutants develop at a normal speed and 6-OHDA must enter dopaminergic neurons to cause dopaminergic neurodegeneration. (A) TTR-33
protein structure prediction based on homology modelling using the structure of TTR-52 (PDB ID: 3UAF). The overlay of the TTR-33 and the TTR-52
structures is shown in S2B Fig. The ttr-33(gt1983) point mutation leading to a glycine to glutamate (G27E) conversion and the ttr-33(gk567379)mutation
leading to a leucine to phenylalanine (L72F) conversion are both indicated in red. (B) Dopaminergic head neurons in wild-type animals and ttr-33 mutants 48
hours after treatment of L1-L4 larval stages or adult animals with 10 mM 6-OHDA. Error bars = SEM of 2 biological replicates, each with 25–45 animals per
stage and strain. Total number of animals per condition n = 50–80 (p<0.0001, p<0.01, n.s. p>0.05; G-Test comparing BY200 wild-type and mutant
animals data of the same lifecycle stages). (C) Developmental stages of wild-type and ttr-33 mutant L1 stage larvae 48 hours after treatment with and without
10 mM 6-OHDA. C. elegans L1 stage larvae develop via the L2 (in red), L3 (in orange), L4 (green) and young adult stage (in light blue) into adults (in dark
blue). Error bars = SEM of 3 biological replicates, each with 60–175 animals per treatment and strain. Total number of animals per condition n = 205–350 (n.
s. p>0.05; G-Test). (D) Effect of dat-1 mutation on dopaminergic neurodegeneration after treatment with 10 mM 6-OHDA. Error bars = SEM of 2
experiments, each with 90–115 animals per strain. Total number of animals per strain n = 200–535 (p<0.0001; G-Test).
https://doi.org/10.1371/journal.pgen.1007125.g002
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ttr-33 mutant animals develop at a slightly slower rate than wild-type animals (S3A Fig),
but do not exhibit increased growth delays after exposure to 6-OHDA (Fig 2C). Thus, ttr-33
mutants exhibit highly increased dopaminergic neurodegeneration at a concentration of
6-OHDA that does not affect their overall development. We also examined whether the ttr-33
mutation affects dopaminergic signalling, yet we found that ttr-33(gt1983)mutants behave like
wild-type animals in assays testing dopamine-mediated behaviours (S3B and S3C Fig). Finally,
ttr-33 mutants do not exhibit loss of dopaminergic neuron when the uptake of 6-OHDA into
these cells is prevented by deletion of the dopamine transporter dat-1 (Fig 2D).
TTR-33 acts independently of TTR-52
We next asked whether TTR-33 and the previously characterised TTR-52 [24–26] have
analogous roles in neuroprotection and axon repair. To test genetic interactions, we also
performed experiments with lower concentrations of 6-OHDA to be able to detect possible
enhanced neurodegeneration due to synergic effects (S4A Fig). We found that a ttr-52 loss-
of-function mutation did not cause increased 6-OHDA-induced neurodegeneration and
did not influence the sensitivity of ttr-33 mutants or wild-type animals (Fig 3A and 3B; S4B
and S4C Fig). Thus, TTR-52 does not appear to play a role in 6-OHDA-induced dopaminer-
gic cell loss. In addition, we performed laser axotomy on the PLM (posterior lateral micro-
tubule cells) mechanosensory neurons of wild-type and ttr-33 mutant animals, using
animals carrying the zdIs5 transgene that express GFP under the control of the mechano-
sensory neuron-specific mec-4 promoter. We found that PLM axons of ttr-33 mutants did
not show overt defects in the rate of axonal regrowth, reconnection or fusion after injury
(Fig 3C and 3D), unlike ttr-52 mutants which have been shown to present a defect in axonal
fusion [27]. In summary, TTR-52 and TTR-33 function appear to have specific and inde-
pendent functions.
The cell corpse engulfment pathway is required for 6-OHDA-induced
dopaminergic neuron death
Given the reported role of TTR-52 in corpse engulfment, we asked if the cell corpse engulf-
ment machinery influences 6-OHDA-induced neurodegeneration. The phagocytosis pathway
consists of two partially redundant branches (for a simplified model see Fig 4A which was
adapted from [27]). One branch involves the TTR-52 bridging molecule, the CED-1 receptor
and the CED-6 adaptor protein. The second pathway involves the CED-2 SH2 and SH3
domain-containing adaptor protein, and the activation of the CED-10/RAC protein via the
bipartite CED-5 and CED-12 guanine nucleotide exchange factor. CED-10 acts as the end
point of both pathways (Fig 4A). We found that mutation in ced-6, in contrast to mutation in
ced-2, led to a measurable suppression of dopaminergic neurodegeneration in the ttr-33
mutant background (Fig 4B; S5A Fig). Furthermore, ced-2;ced-6;ttr-33 triple mutants and ced-
10;ttr-33 double mutants in which both pathways are disrupted, showed an increased suppres-
sion of dopaminergic neuron death compared with ced-6;ttr-33 alone (Fig 4B). Finally, muta-
tions affecting the cell engulfment pathway also led to reduced dopaminergic neuron loss in a
wild-type background (Fig 4C; S5B Fig) with ced-10 single mutants and ced-6;ced-2 double
mutants displaying even less neurodegeneration than ced-2 and ced-6 single mutants (Fig 4C).
Thus, both branches of the cell corpse engulfment pathway are required for 6-OHDA-induced
dopaminergic neuron loss. We note that TTR-52, which has a role in engulfing apoptotic
cells in the CED-5 pathway, had no discernible role in 6-OHDA-induced dopaminergic
neurodegeneration.
Oxidative stress protection by the C. elegans transthyretin-related TTR-33
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Fig 3. ttr-33 and ttr-52 have independent functions. (A) Effect of ttr-52 mutation on dopaminergic neurodegeneration after treatment with 2.5
mM 6-OHDA. Error bars = SEM of 2 biological replicates, each with 95–115 animals per strain. Total number of animals per condition n = 200–
225 (n.s. p>0.05; G-Test). (B) Effect of ttr-52 mutation on dopaminergic neurodegeneration after treatment with 25 mM 6-OHDA. Error
bars = SEM of 4 biological replicates, each with 100–130 animals per strain. Total number of animals per condition n = 425–460 (n.s. p>0.05;
G-Test). (C) Quantification of axonal regrowth, regeneration and fusion of the PLM axons 24 hours after UV-laser axotomy in ttr-33(gt1983)
mutants and wild-type animals carrying the zdIs5 transgene to visualise PLM. The percentage of successful reconnection is a proportion of the
axons that showed regrowth. The percentage of successful axonal fusion is a proportion of the axons that successfully reconnected. Error
Oxidative stress protection by the C. elegans transthyretin-related TTR-33
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bars = standard error of proportion. The number of animals tested is indicated at the bottom of each bar (p<0.05, n.s. p>0.05; t-test). (D) Length
of axonal regrowth in ttr-33(gt1983) mutants and wild-type animals (n.s. p>0.05; t-test).
https://doi.org/10.1371/journal.pgen.1007125.g003
Fig 4. Mutations in the cell corpse engulfment pathway alleviate 6-OHDA-induced dopaminergic neurodegeneration. (A) Cartoon of the engulfment
pathway (adapted from [27]). The recognition of the conserved ‘eat-me’ signal phosphatidylserine (PS) on the surface of apoptotic and necrotic cells triggers
two partially redundant pathways in the engulfing cell [73]. The genes tested in this study are highlighted in yellow and the part of the pathway that was shown
to be required for axon regeneration [27] is boxed in blue. psr = phosphatidylserine receptor family, ced = cell death abnormality, nrf = nose resistant to fluoxetine
(lipid-binding protein). (B) Effect of mutations in engulfment pathway genes on dopaminergic neurodegeneration after treatment with 10 mM 6-OHDA. Error
bars = SEM of 2 biological replicates, each with 70–120 animals per strain. Total number of animals per condition n = 175–230 (p<0.0001, p<0.002,
p<0.01, n.s. p>0.05; G-Test comparing ttr-33 mutant data to double mutant data). (C) Effect of mutations in engulfment pathway genes on dopaminergic
neurodegeneration after treatment with 50 mM 6-OHDA. Error bars = SEM of 2 biological replicates, each with 85–140 animals per strain. Total number of
animals per condition n = 225–235 (p<0.0001, p<0.05, n.s. p>0.05; G-Test).
https://doi.org/10.1371/journal.pgen.1007125.g004
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ttr-33 is likely expressed in pharynx, hypodermis and in posterior arcade
cells
TTR-33 is predicted to be a secreted protein and a transcriptional reporter is thus expected to
highlight the location of protein production. We examined three independent transgenic
strains carrying transcriptional Pttr-33::gfp reporter, and found that six cells residing in the
head of L1 larvae were strongly labelled (Fig 5A and 5B). Two of the labelled cells were located
next to the first pharyngeal bulb and four were situated halfway between the mouth and the
first pharyngeal bulb. All six cells form protrusions towards the mouth of the larva. The cells
were labelled as early as in the embryonic pretzel stage (Fig 5C; S6 Fig, S1 Movie). Comparison
with the cell atlas of C. elegans [30] and a GFP reporter under the control of the grl-27 arcade
cell-specific promoter [31] revealed that these cells represent most likely the posterior arcade
cells, which are located between external epidermis and anterior pharynx [32]. In support of
this notion, we found that expression of wild-type TTR-33 under the arcade cell-specific pro-
moter of bath-15 (C08C3.2) led to a partial rescue of the defect of ttr-33 mutant animals (Fig
1F). In addition, in L1 stage larvae, ttr-33 expression was observed in the pharynx and in sev-
eral unidentified cells immediately posterior to the second pharyngeal bulb. In older animals,
the Pttr-33::GFP transcriptional reporter highlights head cells next to and anterior of the first
pharyngeal bulb, as well as the pharynx and the hypodermis (S6 Fig, S2–S5 Movies). Given
that expression of wild-type TTR-33 under the control of its endogenous regulatory region as
well as the Pbath-15 promoter was not sufficient to fully rescue the enhanced neurodegenera-
tion in ttr-33 mutants, it remains possible that the endogenous gene is expressed in further tis-
sue not visible in these transgenic lines.
Fig 5. Evidence that ttr-33 is expressed in the posterior arcade cells and in the pharynx. (A) Head region of L1 stage
larvae expressing the extrachromosomal transcriptional reporter Ex[Pttr-33::gfp]. Arrows indicate strongly expressing
cells. (B) L1 stage larva expressing the transcriptional reporter Ex[Pttr-33::gfp]. (C) Pretzel stage embryo expression the
transcriptional reporter Ex[Pttr-33::gfp]. The speckled signal is caused by intestinal autofluorescence.
https://doi.org/10.1371/journal.pgen.1007125.g005
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ttr-33 mutants are sensitive to oxidative stress
To determine if ttr-33 mutants are also sensitive to oxidative stress at an organismal level, we
exposed the L1 stage larvae to different concentrations of paraquat and hydrogen peroxide
(H2O2) for 1 hour. We found that after treatment with paraquat (Fig 6A) and H2O2 (Fig 6B),
Fig 6. ttr-33 mutants are sensitive to oxidative stress. (A) Percentage of larvae reaching the L3 larval stage 24 hours after an 1 hour
incubation with indicated concentration of paraquat. Error bars = SEM of 3 biological replicates for 25 and 50 mM paraquat and 2
biological replicates for 0 mM paraquat, each with 60–245 animals per strain and concentration. Total number of animals per condition
n = 275–550 (p<0.0001, p<0.05; two-tailed t-test comparing BY200 wild-type and mutant animal data). (B) Percentage of animals
developed to L3 stage 48 hours after an 1 hour incubation with indicated concentration of H2O2. Error bars = SEM of 2 biological
replicates, each with 165–547 animals per strain and concentration. Total number of animals per condition n = 311–942 (p<0.05; two-
tailed t-test comparing data of BY200 wild-type and mutant animal data at 12.5 and 25 mM H2O2). (C) Lifespan data for first biological
replicate including 110–125 animals per strain. The inset shows the mean lifespan with the error bars depicting the standard error. Total
number of animals for N2 wild-type (which was tested once) n = 110, and for all other strains n = 200–235 (Bonferroni p<0.0001;
Log-Rank Test).
https://doi.org/10.1371/journal.pgen.1007125.g006
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the development of ttr-33 mutants is compromised compared with wild-type animals. Since
increased oxidative stress has been connected to premature aging (for review [1,33]), we asked
whether the lifespan of ttr-33 mutants was altered and found that these animals are indeed
short-lived (Fig 6C, S7 Fig). We next investigated if ttr-33 is transcriptionally regulated in
response to oxidative stress using qRT-PCR and found that this does not appear to be the case
(S8A and S8I Fig; S9A and S9I Fig). Furthermore, to determine if oxidative stress signalling is
altered in ttr-33 mutants as compared to wild-type animals, we measured expression of the oxi-
dative stress reporters gst-1, gst-4 and gcs-1. We found that the ttr-33(gt1983)mutant does not
show overt differences in gst-1, gst-4 and gcn-1 mRNA expression after treatment with
6-OHDA and paraquat or under control conditions (S8 Fig and S9 Fig). In summary, TTR-33
appears to provide a constitutive organism-wide oxidative stress protection.
JNK stress kinases have a role in 6-OHDA-induced neurodegeneration in
ttr-33 mutants
Various MAP kinase pathways are involved in stress signalling (for review [34]), and we there-
fore tested their role in mediating the response to 6-OHDA. We found that mutations in the
p38 kinases PMK-1 (p38 MAP kinase family) and PMK-3 alone did not affect the extent of
neurodegeneration (Fig 7, S10 Fig). However, a possible redundant function of these two pro-
teins cannot be excluded. In contrast, we found that a jnk-1 (Jun N-terminal kinase) mutation
led to increased dopaminergic neuron loss in the ttr-33 mutant (Fig 7A; S10A Fig), but not in
wild-type animals (Fig 7B). Interestingly, mutations in the JNK kinase KGB-1 (kinase, GLH-
binding) strongly alleviated 6-OHDA-induced dopaminergic neurodegeneration in ttr-33
(gt1983)mutants (Fig 8A; S11A Fig) but not in wild-type animals (Fig 8B, S11B Fig). Mutation
of MEK-1, the mitogen-activated protein kinase kinase (MAPKK) acting upstream of KGB-1
[34], equally reduced 6-OHDA-induced dopaminergic neuron loss in the ttr-33 mutant (Fig
8A; S11A Fig), but not in wild-type animals (Fig 8B, S11B Fig). Furthermore, we found that
mutations in kgb-1 and mek-1 decreased paraquat-induced developmental delays in ttr-33
mutants (Fig 8C). However, kgb-1 and mek-1 mutations alone did not induce paraquat sensi-
tivity (Fig 8C). Although mek-1 mutation protects from oxidative stress sensitivity in the ttr-33
mutants, mek-1;ttr-33 double mutants develop slowly and show reduced proliferation (S11C
and S11D Fig). In summary, the KGB-1 MAP kinase pathway appears to mediate the hyper-
sensitivity to oxidative stress associated with ttr-33 mutations.
Discussion
We report that the C. elegans transthyretin-related protein TTR-33 protects against 6-OHDA-
induced dopaminergic neurodegeneration as well as against oxidative stress at an organismal
level. The KGB-1 MAP kinase pathway mediates increased sensitivity to oxidative stress in the
ttr-33 mutant, whereas the JNK-1 MAP kinase pathway provides additional protection. In
addition, we find that the corpse engulfment pathway is required for 6-OHDA-mediated dopa-
minergic neurodegeneration.
We speculate that TTR-33 is part of an endocrine defence system against oxidative stress.
Transthyretin-related proteins form a nematode-specific expanded protein family that com-
prises 59 members, 54 of which are predicted to be secreted [24]. Some transthyretin-related
genes are induced in response to environmental challenges such as oxidative stress or patho-
gen exposure: Oxidative stress induced by tert-butyl hydrogen peroxide leads to upregulation
of several transthyretin-related genes [35], and treatment with the mitochondrial complex I
inhibitor rotenone leads to the upregulation of 42 of the 59 transthyretin-related genes [36].
Furthermore, bacterial infection was reported to cause upregulation of ttr-33 [37] and other
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Fig 7. Interference with the jnk-1 MAPK pathway increases 6-OHDA sensitivity in ttr-33 mutants. (A) Effect of
p38 and JNK stress response pathway mutations on dopaminergic neurodegeneration after treatment with 2.5 mM
6-OHDA. Error bars = SEM of 2–4 biological replicates, each with 100–120 animals per strain and concentration.
Total number of animals per condition n = 200–425 (p<0.05, n.s. p>0.05; G-Test). (B) Effect of p38 and JNK stress
response pathway mutations on dopaminergic neurodegeneration after treatment with 25 mM 6-OHDA. Error
bars = SEM of 3 biological replicates, each with 100–110 animals per strain. Total number of animals per strain
n = 310–330 (n.s. p>0.05; G-Test). (C) Effect of pmk-1 mutation on dopaminergic neurodegeneration after treatment
with 25 mM 6-OHDA. Error bars = SEM of 3 biological replicates, each with 100–135 animals per strain. Total
number of animals per strain n = 350–360 (n.s. p>0.05; G-Test).
https://doi.org/10.1371/journal.pgen.1007125.g007
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transthyretin-related proteins [38]. However, we found that TTR-33 does not appear to be
induced in response to oxidative stress and thus might provide constitutive protection. TTR-
Fig 8. Interference with the kgb-1 MAPK pathway decreases oxidative stress sensitivity in ttr-33 mutants. (A) Effect of kgb-1 MAP kinase
pathway mutations on dopaminergic neurodegeneration after treatment with 10 mM 6-OHDA. Error bars = SEM of 3 biological replicates,
each with 90–115 animals per strain. Total number of animals per strain n = 300–340 (p<0.0001, p<0.001; G-Test). (B) Effect of kgb-1
and mek-1 MAP kinase pathway mutation on dopaminergic neurodegeneration after treatment with 25 mM 6-OHDA. Error bars = SEM of 3
biological replicates, each with 50–130 animals per strain. Total number of animals per strain n = 255–330 (n.s. p>0.05; G-Test). (C)
Percentage of larvae reaching the L3 larval stage 24 hours after an 1 hour incubation with indicated concentration of paraquat. Error
bars = SEM of 3–4 biological replicates for 25 and 50 mM paraquat and 2 biological replicates for 0 mM paraquat, each with 70–270 animals
per strain and concentration. Total number of animals per condition n = 220–650 (p<0.01, p<0.05; two-tailed t-test comparing ttr-33
(gt1983)double mutants to ttr-33(gt1983) single mutant data).
https://doi.org/10.1371/journal.pgen.1007125.g008
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33 possesses 4 cysteine residues that are conserved within the C. elegans transthyretin-related
protein family (marked in yellow in S2B Fig and S12 Fig). These cysteines could serve as reac-
tive oxygen sensors or scavengers, analogous to those in the antioxidant glutathione. TTR-33
is likely produced in the six posterior arcade cells, which form a syncytium and are located
between outer epidermis and the pharynx [32]. At present there is no direct evidence, but we
speculate that TTR-33 could be secreted from the arcade cells into the pharynx. This hypothe-
sis is consistent with the partial rescue we observed upon expressing TTR-33 from an arcade
cell-specific promoter. In the pharynx, TTR-33 could provide organismal protection against
ingested oxidative stress-producing compounds. It will be interesting to experimentally inves-
tigate the mechanistic details of TTR-33 function in the future. ttr-33 gene expression corre-
lates with genes that are associated with the gene ontology terms ‘defence response to fungus’,
‘negative regulation of metalloenzyme activity’ and ‘neuropeptide signalling pathway’ (S1
Table). ttr-33 mutants die prematurely and are hypersensitive to oxidative stress at an organis-
mal level, supporting the idea that these animals might exhibit a compromised organismal
defence system (reviewed in [39]). Alternatively, mutation of ttr-33 could generally lower the
threshold of oxidative damage both for dopaminergic neurons as well as at an organismal
level.
We hypothesise that the KGB-1 and the JNK-1 MAPK pathways influence 6-OHDA-medi-
ated neurodegeneration in the ttr-33 mutant based on their role in organismal stress responses.
KGB-1 is ubiquitously expressed [40,41] and was reported to transmit a neuroendocrine signal
that mediates a food aversion behaviour upon disruption of core cellular processes such as
translation, respiration and protein turnover [42]. It is conceivable that KGB-1 acts upstream
of TTR-33. However, the kgb-1 mutant on its own does not show enhanced 6-OHDA-induced
neuronal loss. It is thus possible that the KGB-1 pathway senses the pathology conferred by the
combination of exposure to oxidative stress and TTR-33 deficiency analogous to its described
roles in sensing cellular defects [42]. Such sensing mechanisms might promote the degenera-
tion of damaged neurons. In contrast, the JNK orthologues JNK-1 protects against 6-OHDA-
induced neurodegeneration in the ttr-33 mutant. This phenotype is consistent with the
reported role of JNK-1 in protecting against oxidative stress [43,44].
The C. elegans corpse engulfment pathway could promote 6-OHDA-induced dopaminergic
neurodegeneration by driving the phagocytosis of dopaminergic neurons. Morphological evi-
dence for 6-OHDA-induced engulfment of dopaminergic neurons were reported [13,45].
However, it is not known exactly how dopaminergic neurons die. The engulfment pathway
typically acts by eliminating apoptotic cell corpses, but has also been shown to promote cell
death; mutations in the engulfment pathway enhance C. elegans apoptosis defects [15,17] and a
small number of cell deaths are mediated by cell killing conferred by the engulfment machin-
ery [18,19,46]. Consistent with our findings, reduced axonal degeneration in neurons whose
axons have been severed has been observed in mutants with a defective engulfment machinery
[47]. It is still poorly understood how dopaminergic neurons die in Parkinson’s disease
patients. Active phagocytic cells in the brain are observed in almost all neurological diseases
including Parkinson’s disease (for review [48,49]), as well as in 6-OHDA models of Parkin-
son’s disease (for review [50]). The C. elegans 6-OHDA model, in which the conserved engulf-
ment pathway has a role in cell removal, might recapitulate important features of this disease.
Methods
We note that experiments shown in this paper were done in parallel to experiments shown in
the accompanying paper ‘Mutations in Caenorhabditis elegans neuroligin-like glit-1, the
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apoptosis pathway and the calcium chaperone crt-1 increase dopaminergic neurodegeneration
after 6-OHDA treatment’ and thus share the wild-type control.
C. elegans strains and maintenance
Strains were grown at 20˚C unless indicated otherwise. Additional information about alleles in
this study is provided by WormBase (www.wormbase.org) [51]. Strains from the Caenorhabdi-
tis Genetics Center (CGC) or the National BioResource Project (NBRP) were outcrossed to the
BY200 strain to eliminate unlinked mutations and to introduce a green fluorescent protein
(GFP) marker for dopaminergic neurons. The strain carrying the second ttr-33 allele gk567379
(generated as part of the Million Mutation project [52]) was identified with WormBase [51]
and ordered from CGC. Both The isolated gt1983mutant and the ttr-33(gk567379)mutant
were outcrossed a minimum of six times to the BY200 strain.
BC15279 dpy-5(e907) I; sEx15279. sEx15279[rCes grl-27::gfp+ pCeh361] [53]
BY200 vtIs1[pdat-1::gfp; rol-6] V (while pdat-1::gfp is always expressed, the penetrance of
the roller phenotype is very low, only rarely detectable)
CZ10175 zdIs5 [Pmec-4::gfp]
N2 Bristol
QH6342 zdIs5 I; ttr-33(gt1983)V
TG2395 cat-2(e1112) II; vtIs1 V
TG2400 dat-1(ok157) III; vtIs1 V
TG4103 ttr-33(gt1983)V; vtIs1 V
TG4104 ttr-33(gk567379)V; vtIs1 V
TG4106 dat-1(ok157) III; ttr-33(gt1983)V; vtIs1 V
TG4120 pmk-1(km25) IV; vtIs1 V
TG4121 pmk-1(km25) IV; ttr-33(gt1983) V; vtIs1 V
TG4122 jnk-1(gk7) IV; vtIs1 V
TG4123 jnk-1(gk7) IV; ttr-33(gt1983) V; vtIs1 V
TG4124 pmk-3(ok169) IV; vtIs1 V
TG4125 pmk-3(ok169) IV; ttr-33(gt1983) V; vtIs1 V
TG4126 kgb-1(km21) IV; vtIs1 V
TG4154 ced-2(e1752) IV; vtIs1 V
TG4155 ced-2(e1752) IV; ttr-33(gt1983) V; vtIs1 V
TG4156 ced-6(n1813) III; vtIs1 V
TG4157 ced-6(n1813) III; ttr-33(gt1983) V; vtIs1 V
TG4158 ced-10(n3246) IV; vtIs1 V
TG4159 ced-10(n3246) IV; ttr-33(gt1983) V; vtIs1 V
TG4160 ttr-52(sm211) III; vtIs1 V
TG4161 ttr-52(sm211) III; ttr-33(gt1983) V; vtIs1 V
TG4170 unc-119(ed3) III; cxTi10816 IV; gtEx4170[Pttr-33::gfp::3’ttr-33, Pmyo-2::mCherry,
Pmyo-3::mCherry] a
TG4171 vtIs1 V; CB4856
TG4281 unc-119(ed3) III; cxTi10816 IV; gtEx4170[Pttr-33::gfp::3’ttr-33, Pmyo-2::mCherry,
Pmyo-3::mCherry] b
TG4282 unc-119(ed3) III; cxTi10816 IV; gtEx4170[Pttr-33::gfp::3’ttr-33, Pmyo-2::mCherry,
Pmyo-3::mCherry] c
TG4283 kgb-1(km21) IV; ttr-33(gt1983) V; vtIs1 V
TG4284 kgb-1(um3) IV; ttr-33(gt1983)V; vtIs1 V
TG4285 ttr-33(gt1983)V; vtIs1 V; mek-1(ks54) X
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TG4286 kgb-1(um3) IV; vtIs1 V
TG4336 ttTi5605 II; gtIs4336[Pbath-15::ttr-33::3’ttr-33, unc-119(+), integration into
ttTi5605 MosSCI site] II; unc-119(ed9) III
TG4337 ttTi5605 II; gtIs4337[Pttr-33::ttr-33::3’ttr-33, unc-119(+), integration into ttTi5605
MosSCI site] II; unc-119(ed9) III
TG4338 ttTi5605 II; unc-119(ed9) III. gtEx4338[Pbath-15::ttr-33::3’ttr-33,unc-119(+),
Pmyo-2::mCherry, Pmyo-3::mCherry] a
TG4339 ttTi5605 II; unc-119(ed9) III. gtEx4338[Pbath-15::ttr-33::3’ttr-33,unc-119(+),
Pmyo-2::mCherry, Pmyo-3::mCherry] b
TG4340 ttTi5605 II; unc-119(ed9) III. gtEx4338[Pbath-15::ttr-33::3’ttr-33,unc-119(+),Pmyo-
2::mCherry,Pmyo-3::mCherry] c
TG4341 ttTi5605 II; unc-119(ed9) III. gtEx4341[Pttr-33::ttr-33::3’ttr-33,unc-119(+), Pmyo-
2::mCherry,Pmyo-3::mCherry] a
TG4342 ttTi5605 II; unc-119(ed9) III. gtEx4341[Pttr-33::ttr-33::3’ttr-33,unc-119(+), Pmyo-
2::mCherry,Pmyo-3::mCherry] b
TG4343 ttTi5605 II; unc-119(ed9) III. gtEx4341[Pttr-33::ttr-33::3’ttr-33,unc-119(+), Pmyo-
2::mCherry,Pmyo-3::mCherry] c
Mutagenesis and mapping
L4 and young adult staged BY200 animals were mutagenised with 25 mM ethyl methanesulfo-
nate in M9 buffer for 4 hours at 20˚C, washed and grown at 15˚C overnight on NGM plates
seeded with OP50 E. coli. The animals were bleached once they started to lay eggs and the F1
progeny left to hatch overnight in M9. This synchronised F1 population was left to develop on
seeded plates until reaching early adult stage. The F1 adults were then washed off in M9 to lay
a synchronised population of F2 L1 larvae, which were then treated with 10 mM 6-OHDA and
screened for dopaminergic neuron loss after 72 hours. Candidates were picked on separate
plates, backcrossed at least three times and re-tested for their hypersensitivity to 6-OHDA.
The genomic DNA was sent for whole-genome sequencing and SNP mapping was performed
as previously described [28,29]. SNP mapping combined with whole-genome sequencing
revealed that the location of the phenotype-causing mutation could be narrowed down to an
interval between 4 and 9 Mb on chromosome V. This region, besides ttr-33, contained two
other exon-altering mutations that were excluded by testing a deletion allele (fbxa-223) and by
fosmid injection (F43H9.4). ttr-33 identity was further confirmed by genetic rescue and by
complementation testing using the second allele ttr-33(gk567379)which was obtained from the
CGC.
C. elegans assays
All assays were performed in a blinded manner.
For 6-OHDA assays, 1–10 adult animals were incubated to lay eggs in 70 μL M9 without
food on a shaker at 20˚C, 500 rpm for 24–30 h. 10 μL 200 mM ascorbic acid and 10 μL of the
respective 6-OHDA 5x stock concentration were freshly prepared in H2O and added to 30 μL
of L1-stage larvae in M9. 6-OHDA concentrations were chosen such that differential sensitives
of various strains could be efficiently analysed. After 1 hour incubation at 20˚C and shaking at
500 rpm, 150 μL M9 buffer was added to oxidise and inactivate the 6-OHDA. The animals
were pipetted to one half of an NGM plate containing a stripe of OP50 bacteria on the opposite
half of the plate and adult animals and eggs were picked off to prevent growth of those that
were not treated at L1 stage. Plates were incubated at 20˚C before examining the 6-OHDA-
induced degeneration using a Leica fluorescent dissecting microscope. Unless otherwise
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indicated, head dopaminergic neurons (ADE and CEP neurons) were scored 72 hours after
treatment in technical duplicates. Posterior deirid (PDE) dopaminergic neurons, which are
formed later in L2 stage larvae, did not appear to be affected by 6-OHDA treatment, as previ-
ously observed [13]. For treatment of different developmental stages, the respective stages
were picked after 6-OHDA treatment from a mixed population of animals.
For paraquat and hydrogen peroxide (H2O2) assays, 10 μL of the 5x paraquat or H2O2
stock concentration was freshly prepared and added to 40 μL of filtered L1-stage larvae in M9.
After 1 hour incubation in the shaker, 150 μL M9 buffer was added and the L1 larvae were
counted after pipetting approximately 100 of them to a seeded NGM plate. After 24 hours, ani-
mals that reached L3 larval stage were examined and scored.
For laser axotomy and microscopy, animals were immobilised in 0.05% tetramisole hydro-
chloride on 3.5% agar pads. Axotomies were performed as previously described [54], using a
MicroPoint Laser System Basic Unit attached to a Zeiss Axio Imager A1 (Objective EC Plan-
Neofluar 100X/1.30 Oil M27). Axons were severed in L4 stage animals 50 μm anterior to the
PLM cell body, visualised on a Zeiss Axio Imager Z1 microscope equipped with a Photo-
metrics camera (Cool Snap HQ2; Tucson, AZ) and analysed with MetaMorph software
(Molecular Devices, Sunnyvale, CA) or Image J. Animals were analysed 24 hours post-axot-
omy for regrowth, reconnection and fusion. Regrowth was recorded as the length of regenera-
tive growth from the proximal side of the cut site: the proximal axon was traced from the start
of regrowth to the tip of the longest regenerative branch using Metamorph software; neurons
that underwent axonal fusion were excluded from these quantifications. Axons were deemed
to be reconnected when the proximal and distal axons appeared connected and within the
same focal plane when observed with a 63X objective. Axonal fusion was defined as proximal-
distal reconnection that prevented the onset of degeneration in the distal axon. For clarifica-
tion of successful fusion, animals were re-analysed at 48 hours and/or 72 hours post-axotomy
as necessary.
For lifespan assays, 50 L4 stage animals were picked for each strain and moved to new
plates every day during the first 6 days and again at later days to avoid mixing with the prog-
eny. Animals that did not move after being touched with a platinum pick were scored as dead.
Dead animals were counted and removed every day. ‘Bag of worms’ and dry and burst animals
were not included in the lifespan analysis. The data was analysed using OASIS (Online applica-
tion for Survival Analysis, http://sbi.postech.ac.kr/oasis/) [55].
For egg-laying and development assays, over 20 L4 stage animals per strain were picked
separately 24 hours before the assay. On the day of the assay, two plates per strain were seeded
with concentrated OP50 E. coli and ten adults each deposited onto the plates. The adults were
left to lay eggs for 1.5 hours, removed from the plate and the eggs counted. Developmental
stages were determined at 48 and 61 hours, respectively, after egg-laying.
Dopamine paralysis assays were carried out as previously described [56]. Well-fed adults
24 hours post the L4 stage were incubated for 20 min on a plate containing different concen-
trations of dopamine. Animals were scored as paralysed when they failed to complete a full
sinusoidal body movement during a 5 second observation period. Two plates containing 25
animals each were assessed for each condition.
Basal slowing assays were performed as previously described [57]. NGM plates were pre-
pared and half of them seeded with HB101 E. coli before incubating them at 37˚C overnight.
Also, mid-L4 larvae were picked separately on seeded plates. The next day, these staged, well-
fed young adult animals were placed in 40 μL of M9 for 2 minutes to clean them from bacteria,
and then picked to the centre of a plate. 6 animals each were put on a plate with and without
bacteria. After 2 minutes adaptation time, the locomotion rate of each animal was quantified
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by counting the number of body bends completed in five consecutive 20 s intervals. The exper-
iment was performed twice on different days.
qRT-PCR
L1 stage animals were filtered using an 11 μm filter from two 9 cm plates containing mixed
stage animals. Animals were washed twice and the population was split in half for control
treatment and drug treatment. For the 6-OHDA assays, ascorbic acid and H2O was added to
the control wells and 10 mM 6-OHDA to the treated animals. For paraquat assays, H2O was
added to the control wells and 25 mM paraquat to the treated animals. After 1 hour of treat-
ment, RNA extraction was performed based on [58] using Trizol (Thermo Fisher Scientific).
The following changes were introduced. The chloroform extraction was repeated once more
and 0.1 volumes of 3 M sodium acetate was added to the propanol extraction to help RNA pre-
cipitation. The RNA pellet was resuspended in 15 μL H2O. The gDNA was digested using the
Turbo DNA-free kit (Ambion Life Technologies) in a total volume of 18 μL. 1 μg of RNA was
reverse transcribed to cDNA with 15 bp oligo dT primers using the M-MLV Reverse Tran-
scriptase (Promega) according to manufacturers’ instructions. The cDNA was analysed by
qRT-PCR using the StepOnePlus Real-Time PCR System (Applied Biosystems) applying melt-
ing temperature of 62˚C. The following primers were designed using QuantPrime [59]: ttr-33/
C37C3.13.2_F: ACCCAATCAGCTGGAGTTAAGGG and ttr-33/C37C3.13.2_R: ATCCGGT
CCGGTATCATCATCG, gst-4/K08F4.7_F: ATGGTCAAAGCTGAAGCCAACG and gst-4/
K08F4.7_R: ACTGACCGAATTGTTCTCCATCG, gcs-1/F37B12.2.1_F: GTTGATGTGGAT
ACTCGGTGTACG and gcs-1/F37B12.2.1_R: ATCTCTCCAGTTGCTCGTTTCG, gst-1/
R107.7.1_F: CGTCATCTCGCTCGTCTTAATGGG and gst-1/R107.7.1_R: TGGTGTGCA
AATCACGAAGTCC, Y45F10D.4_F: TTGCCTCATCTTCCCTGGCAAC and Y45F10D.4_R:
GTCTTGGGCGAGCATTGAACAG, pmp-3/C54G10.3b_F: ACTTGCTGGAGTCACTCA
TCGTG and pmp-3/C54G10.3b: TCAAGGCAATCCGAGTGAAGACG. The PCR mixture
consisted of 0.2 μM primers, cDNA (diluted 1:50) and 1x Power SYBR Green PCR Master Mix
(Thermo Fisher Scientific). All reactions were run in technical triplicates. Relative abundance
was calculated using the ΔΔCt method [60]. To control for template levels, values were normal-
ised against the control genes Y45F10D.4 and pmp-3 [61,62].
Bioinformatics analysis
The open reading frame and exon-intron structure of ttr-33 was derived from information
compiled in WormBase (www.wormbase.org) [51]. Extra- and intracellular and transmem-
brane protein domains and signal peptides were predicted with Phobius (http://phobius.sbc.
su.se/) [63]. The protein structure model was calculated in SWISS-MODEL (swissmodel.
expasy.org) [64] and visualised with Swiss-PdbViewer 4.1.0 (http://www.expasy.org/spdbv/)
[65]. Jalview Version 2.9.0b2 (www.jalview.org) was used for phylogenetic alignment (Clus-
talWS version 2.0.12 with default settings) [66]. Secondary structure prediction was performed
with JPred4 [67] in Jalview [68]. For the correlated gene expression analysis, 100 result genes
calculated by SPELL (Serial Pattern of Expression Levels Locator) Version 2.0.3.r71 (http://spell.
caltech.edu:3000/) were considered. Given a query gene, SPELL searches for genes with corre-
lated expression patterns based on available microarray, RNAseq and tiling array data (currently
5264 experiments in 315 datasets). The main algorithm is described in [69].
Statistical analysis
The two-tailed t-test was performed with the Analysis ToolPak Add-In in Microsoft Excel
2010. To choose between a t-test assuming equal or unequal variances, an F-test was conducted
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with the Analysis ToolPak Add-In. A G-Test was performed with the R Studio 1.0.44 Desc-
Tools descriptive statistics tools package to compare 6-OHDA treatment data. p-values were
calculated for each biological replicate and for the pooled biological replicate data, and the
least significant of these p-values is indicated in the graphs. Data is only marked as statistically
significant if all replicates and the pooled replicate data were found to be significant. Statistical
analysis for axonal regeneration was performed using GraphPad Prism and Microsoft Excel.
Two-way comparison was performed using the t-test.
DNA cloning and generation of transgenic lines
For generation of transgenic constructs, genomic DNA was amplified using primers contain-
ing additional 8 base pair restriction sites (marked in italics) for insertion into the pCFJ151
and the pCFJ212 vector for insertions on chromosome II and IV, respectively [70]. In the fol-
lowing primer sequences, restriction sites are highlighted in italics, translation start and trans-
lation stop codons in bold. Primers for the transcriptional reporter construct AscI–Pttr-33 –
NotI–GFP–FseI– 3’ttr-33 –PacI: AscI_Pttr-33 –GTACTTggcgcgccCAAAGAAACTTGCGTG
TTTC, Pttr-33_NotI–AAGGAAAAAAgcggccgcaCATTATTTTTGTCTGAAAATACAAAC
AC, NotI_GFP—GCTAgcggccgcAGTAAAGGAGAAGAACTTTTCACTGG, GFP_FseI—TT
ATTAggccggccCCTTGTATGGCCGGCTAG, FseI_3’ttr-33—ACAAGGggccggccTAATAAT
TATACTTAAAAGTATTTTCAACTG, 3’ttr-33_PacI–GCTAttaattaaGCATGCATCTTCCC
ATAAAAG. Additional primers for the translational construct AscI–Pttr-33 –NotI–TTR-33 –
FseI– 3’ttr-33 –PacI: NotI_TTR-33 –AAGGAAAAAAgcggccgcTCACGACTCGCGTGCATT,
TTR-33_FseI–AGAAAAggccggcctTCTGTGAAGACAGTCACGTGACTC. The Pttr-33 pro-
moter sequence in these constructs ranges from -1500 to the translational start site. The pre-
dicted promoter sequence of ttr-33 ranges from -499 to 100 bp with respect to the translational
start site [71]. Additional primers for the translational construct AscI–Pbath-15 –NotI–TTR-33
–FseI– 3’bath-15 –PacI: AscI_Pbath-15: GTACTTggcgcgccTTTTCACTTTTTTTGGTCAGA
ATC, Pbath-15_NotI: AAGGAAAAAAgcggccgccCATTTTGAAGAGTTTGCTG, FseI_3’bath-
15: CTCATAggccggccTAATCATTTTTTTCCTGTTTTAGC, 3’bath-15_PacI: GAGACCttaat-
taaCTGGAGTTCACCACTACAAC. For single-copy integration of transgene according to
[70], 5 ng/μL of the constructs were injected into unc-119 animals, together with one or two
fluorescent co-injection marker(s) (2.5 ng/μL Pmyo-2::mCherry to label the pharynx and 5 ng/
μL Pmyo-3::mCherry to label the bodywall), and the Mos transposase under the control of the
eft-3 promoter as described [72]. Wild-type moving animals that did not show expression of
the fluorescent co-injection markers were singled out and tested for transgene integration by
PCR. Extrachromosomal lines in contrast were identified by expression the fluorescent co-
injection markers as well as by the appearance of UNC animals. At least three independent
transgenic lines were analysed for all translational and transcriptional constructs.
Supporting information
S1 Fig. Effect of single-copy transgenes on 6-OHDA hypersensitivity of ttr-33 mutant.
Effect of Pttr-33::ttr-33 and Pbath-15::ttr-33 single copy integration on dopaminergic neurode-
generation of ttr-33 mutant animals after treatment with 10 mM 6-OHDA. Error bars = SEM
of 2 biological replicates, each with 50–105 animals per strain and concentration. Total num-
ber of animals per condition n = 150–205 (n.s. p>0.05; G-Test).
(EPS)
S2 Fig. TTR-33 protein structure prediction. (A) TTR-33 signal peptide (in red) and non-
cytoplasmic part (in blue) as determined using the Phobius webserver [63] (http://phobius.sbc.
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su.se/). No transmembrane domains (in grey) and no cytoplasmic parts (in green) were pre-
dicted. (B) TTR-33 secondary structure with helices (red tubes) and beta strands (green
arrows) as predicted by JPred4 [67]. (C) Predicted TTR-33 structure (in grey with indicated
mutated sites in red and cysteine bridges in yellow) with superimposed TTR-52 structure (in
black). The small TTR-52 α-helix (top right part of structure) is likely an artefact caused by
mutations that were introduced for crystallisation [25].
(TIF)
S3 Fig. Development and dopamine-mediated behaviours of ttr-33 mutants. (A) Develop-
mental stages of wild-type and ttr-33 mutant embryos 48 and 61 hours after egg-laying. Error
bars = SEM of 3 biological replicates, each with 40–230 animals per strain. Total number of
animals n = 405–515 (p<0.05, n.s. p>0.05; G-Test). (B) Dopamine paralysis assay: Ability of
young adult animals to move on plates with indicated concentrations of dopamine. Error
bars = StDev of 2 technical replicates, each with 25 animals per strain and condition. Total
number of animals per condition n = 50. (n.s. p>0.05; two-tailed t-test comparing wild-type
and mutant animal data at 100 mM dopamine). (C) Basal slowing response: Ability of young
adult animals to slow down on a lawn of bacteria. The tyrosine hydroxylase mutant cat-2
(abnormal catecholamine distribution) is deficient of dopamine synthesis. The values for each
animal are depicted with grey symbols and the average across animals is indicated with a black
bar. Error bars = SEM of 2 biological replicates, each with 6 animals per strain and state. Total
number of animals per condition n = 12 (p<0.000001, p<0.05; two-tailed t-test).
(TIF)
S4 Fig. 6-OHDA concentration gradient and effect of ttr-52 mutations on dopaminergic
neurodegeneration. (A) Dopaminergic neurodegeneration in wild-type and ttr-33(gt1983)
mutant animals after treatment with a distinct concentrations of 6-OHDA. Error bars = SEM
of 2 biological replicates, each with 75–120 animals per strain. Total number of animals per
condition n = 180–220. (B) Effect of ttr-52 mutation on dopaminergic neurodegeneration after
treatment with 10 mM 6-OHDA. Error bars = SEM of 2 biological replicates, each with 65–
110 animals per strain. Total number of animals per condition n = 165–220 (n.s. p>0.05;
G-Test). (C) Effect of ttr-52 mutation on dopaminergic neurodegeneration after treatment
with 50 mM 6-OHDA. Error bars = SEM of 4 biological replicates, each with 100–125 animals
per strain. Total number of animals per condition n = 430–440 (n.s. p>0.05; G-Test).
(EPS)
S5 Fig. Effect of mutations in the cell corpse engulfment pathway on dopaminergic neuro-
degeneration. (A) Effect of mutations in engulfment pathway genes on dopaminergic neuro-
degeneration after treatment with 2.5 mM 6-OHDA. Error bars = SEM of 2 biological
replicates, each with 100–110 animals per strain. Total number of animals per condition
n = 200–220 (p<0.0001, n.s. p>0.05; G-Test). (B) Effect of mutations in engulfment path-
way genes on dopaminergic neurodegeneration after treatment with 25 mM 6-OHDA. Error
bars = SEM of 2 biological replicates, each with 85–140 animals per strain. Total number of
animals per condition n = 205–230 (p<0.0001, p<0.001, p<0.01, n.s. p>0.05;
G-Test).
(EPS)
S6 Fig. Pttr-33::gfpexpression in different developmental stages of C. elegans (snapshots of
supplementary movies). Head cells (likely arcade cells) are labelled with arrowheads, epider-
mal staining with arrows.
(TIF)
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S7 Fig. ttr-33 mutant lifespan. Lifespan data for second biological replicate including 85–110
animals per strain. The inset shows the mean lifespan with the error bars depicting the stan-
dard error (Bonferroni p0.0001; Log-Rank Test).
(TIF)
S8 Fig. Transcript levels of ttr-33, gst-4, gcs-1 and gst-1 normalised against the control gene
Y45F10D.4. (A) ttr-33, (B) gst-4, (C) gcs-1 and (D) gst-1 mRNA levels in wild-type and ttr-33
mutant L1 stage larvae after treatment with 10 mM 6-OHDA. (E) ttr-33, (F) gst-4, (G) gcs-1
and (H) gst-1 mRNA levels in ttr-33 mutants at L1 stage as compared to wild-type larvae under
control conditions (no 6-OHDA exposure). (I) ttr-33, gst-4, gcn-1 and gst-1 mRNA levels in
wild-type and ttr-33 mutant L1 stage larvae after treatment with 25 mM paraquat. (A)-(I) The
data are normalised to the control gene Y45F10D.4 [61,62]. The average and the respective val-
ues for the biological replicates (biorep a-f) are indicated. Error bars = SEM of 5–6 biological
replicates (n.s. p>0.05).
(TIF)
S9 Fig. Transcript levels of ttr-33, gst-4, gcs-1 and gst-1 normalised against the control gene
pmp-3. (A) ttr-33, (B) gst-4, (C) gcs-1 and (D) gst-1 mRNA levels in wild-type and ttr-33
mutant L1 stage larvae after treatment with 10 mM 6-OHDA. (E) ttr-33, (F) gst-4, (G) gcs-1
and (H) gst-1 mRNA levels in ttr-33 mutant at L1 stage as compared to wild-type larvae under
control conditions (no 6-OHDA exposure). (I) ttr-33, gst-4, gcn-1 and gst-1 mRNA levels in
wild-type and ttr-33 mutant L1 stage larvae after treatment with 25 mM paraquat. (A)-(I) The
data are normalised to the control gene pmp-3 (C54G10.3b) [61,62]. The average and the
respective values for 5–6 biological replicates (biorep a-f) are indicated. Error bars = SEM of
5–6 biological replicates (p<0.01, p<0.05; n.s. p>0.05; two-tailed t-test).
(TIF)
S10 Fig. Effect of MAPK pathway mutations on dopaminergic neurodegeneration. (A)
Effect of p38 and JNK stress response pathway mutations on dopaminergic neurodegeneration
after treatment with 10 mM 6-OHDA. Error bars = SEM of 2–3 biological replicates, each with
100–115 animals per strain and concentration. Total number of animals per condition
n = 100–315 (p<0.001, n.s. p>0.05; G-Test). (B) Effect of p38 and JNK stress response path-
way mutations on dopaminergic neurodegeneration after treatment with 50 mM 6-OHDA.
Error bars = SEM of 3 biological replicates, each with 100–110 animals per strain. Total num-
ber of animals per strain n = 305–320 (n.s. p>0.05; G-Test).
(TIF)
S11 Fig. Effect of kgb-1 MAPK pathway mutations on dopaminergic neurodegeneration
and development. (A) Effect of kgb-1 MAP kinase pathway mutations on dopaminergic neu-
rodegeneration after treatment with 2.5 mM 6-OHDA. Error bars = SEM of 2–3 biological
replicates, each with 95–120 animals per strain. Total number of animals per strain n = 200–
340 (p<0.0001, p<0.001; G-Test). (B) Effect of kgb-1 MAP kinase pathway mutations
on dopaminergic neurodegeneration after treatment with 50 mM 6-OHDA. Error bars = SEM
of 3 biological replicates, each with 100–125 animals per strain. Total number of animals per
strain n = 205–335 (n.s. p>0.05; G-Test). (C) Number of laid eggs per animal per hour. Error
bars = SEM of 3–4 biological replicates, each with 20 animals per strain. Total number of ani-
mals n = 60–80 (two-tailed t-test). (D) Developmental stages of wild-type and mutant embryos
48 hours after egg-laying. Error bars = SEM of 3 biological replicates, each with 40–125 ani-
mals per strain. Total number of animals n = 150–350 (p<0.01; two-tailed t-test).
(TIF)
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S12 Fig. Alignment of C. elegans transthyretin-related proteins. Amino acids above an iden-
tity threshold of 69 are coloured according to their physicochemical properties using the
Zappo colour code. Conservation score, quality and consensus are each shown as a bar graph
in the bottom of the alignment.
(TIF)
S1 Table. Gene Ontology (GO) term analysis for genes for which the expression pattern
correlated with ttr-33. Genes with expression patterns correlating to the ttr-33 expression pat-
tern were predicted using SPELL [69]–The GO terms and the according genes are sorted by p-
value. The number of genes that are associated with this GO term out of all genes with a similar
expression pattern to ttr-33, and out of all genes in the genome, are shown in column ‘%
Query’ and ‘% Genome’, respectively. Very specific processes that are associated with few
genes in the genome are marked in blue.  Similar GO terms based on the same group of genes
were merged.
(XLSX)
S1 Movie. Pttr-33::gfpexpression in C. elegans embryo.
(AVI)
S2 Movie. Pttr-33::gfpexpression in L2 stage C. elegans larva.
(AVI)
S3 Movie. Pttr-33::gfpexpression in L3 stage C. elegans larva.
(AVI)
S4 Movie. Pttr-33::gfpexpression in L4 stage C. elegans larva.
(AVI)
S5 Movie. Pttr-33::gfpexpression in young adult C. elegans.
(AVI)
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